CRISPR has revolutionized the way we engineer genomes. Its simplicity and modularity have enabled the development of a great number of tools to edit genomes and to control gene expression. This powerful technology was first adapted to Bacillus subtilis in 2016 and has been intensely upgraded since then. Many tools have been successfully developed to build a CRISPR toolbox for this Gram-positive model and important industrial chassis. The toolbox includes tools, such as double-strand and single-strand cutting CRISPR for point mutation, gene insertion, and gene deletion up to 38 kb. Moreover, catalytic dead Cas proteins have been used for base editing, as well as for the control of gene expression (CRISPRi and CRISPRa). Many of these tools have been used for multiplex CRISPR with the most successful one targeting up to six loci simultaneously for point mutation. However, tools for efficient multiplex CRISPR for other functionalities are still missing in the toolbox. CRISPR engineering has already resulted in efficient protein and metabolite-producing strains, demonstrating its great potential. In this review, we cover all the important additions made to the B. subtilis CRISPR toolbox since 2016, and strain developments fomented by the technology. Graphical abstract
Autonomous control of gene expression through engineered quorum-sensing processes is broadly applicable to biosynthetic pathways, including simultaneous control of different genes. It is also a powerful tool for balancing growth and production. We had previously engineered a modular autoinduction device for the control of gene expression in B. subtilis. Now, we expand its functionality to repress gene expression autonomously. The engineered R8 promoter responds to AHL accumulation in the culture medium. In a riboflavin-producing strain, the AHL-Lux complex exerts 5-fold repression on the R8-driven expression of the flavokinase/FAD synthetase gene ribC, resulting in a higher titer of the vitamin. We engineered a strain able to autonomously induce and repress different genes simultaneously, demonstrating the potential of the device for use in metabolic engineering.
Bacillus subtilis ∆6 is a genome-reduced strain derived from the laboratory strain 168 through deletion of six prophages and AT-rich islands. The parental and the genome-reduced strains were edited to restore the capacity to synthesize surfactin. Although the genome deletions are not directly related to surfactin biosynthesis, the ∆6 strain produces more surfactin while building lower biomass compared to the parental strain. Further editions to ∆6, such as srfA promoter replacement, codY deletion, and comA overexpression, were deleterious to surfactin production. The results showcase that the ∆6 is metabolically distinct from its parental strain and other surfactin-producing strains, as the gene editions made have been previously described to increase surfactin production in these strains. The ∆6 produced the highest surfactin titer, rate, and yield in LB medium enriched with glucose, compared to other commonly used media for B. subtilis. This work demonstrates the enhanced capacity of a genome-reduced strain to produce surfactin compared to the parental strain, as well as the metabolic changes resulting from genome engineering.
A proper balance of metabolic pathways is crucial for engineering microbial strains that can efficiently produce biochemicals at an industrial scale while maintaining cell fitness. High production loads can negatively impact cell fitness and hinder industrial-scale production. To address this, fine-tuning of gene expression using engineered promoters and genetic circuits can promote control over multiple targets in pathways and reduce the burden. We took advantage of the robust carbon catabolite repression system of Bacillus subtilis to engineer a glucose-inducible genetic circuit that supports growth and production. By simulating cultivation scale-up under repressive conditions, we preserved the production capacity of cells, which could be fully accessed by switching to glucose in the final production step. The circuit is also resilient, enabling a quick switch in the metabolic status of the culture. Furthermore, the simulated scale-up process selected best-growing cells without compromising their production capability, leading to higher product formation at the end of the process. As a pathwayindependent circuit activated by the preferred carbon source, our engineered glucose-inducible genetic circuit is broadly useful and imposes not additional cost to traditional production processes.
Two genetically engineered Bacillus subtilis strains, BMV9 and BsB6, were evaluated in terms of culture medium (effect of nutrients on surfactin yield) and potential biotechnological applications of surfactin in agriculture and the petrochemical industry. BMV9 (spo0A3; abrB*; ΔmanPA; sfp+) is, to date, the highest surfactin producer reported scientifically, and BsB6 is a sfp+ laboratory derivative strain that has also demonstrated considerable production potential. To assess their performance, fermentation experiments were conducted in shake flasks using two different culture media, a mineral salt medium and a complex medium, each supplemented with 2% (w/v) glucose. Lipopeptides (surfactin and fengycin) were extracted and quantified at multiple time points (up to 48 h) via high-performance thin-layer chromatography (HPTLC). Optical density, residual glucose, and pH were monitored throughout the cultivation. In parallel, microbial growth in both media were also validated in small-scale cultivation approaches. Antifungal activity of culture supernatants and lipopeptide extracts was tested against two Diaporthe species, key phytopathogens in soybean crops. Given the agricultural relevance of these pathogens, the biocontrol potential of lipopeptides represents a sustainable alternative to conventional chemical fungicides. Additionally, oil displacement tests were performed to evaluate the efficacy of surfactin in enhanced oil recovery (EOR), bioremediation, and related petrochemical processes. High-resolution LC-MS/MS analysis enabled structural characterization and relative quantification of the lipopeptides. Overall, these investigations provide a comprehensive comparison of strain production performance and the associated impact of cultivation media, aiming to define the optimal conditions for economically viable surfactin production and to explore its broader biotechnological applications in agriculture and the petrochemical industry.
We introduce LeDNA, a versatile educational toolkit designed for teaching fundamental genetics and CRISPR-Cas gene editing principles in diverse settings, regardless of existing infrastructure. Fabricated using laser-cutting techniques, LeDNA is an open-source resource suitable for students across educational levels, from high school to graduate studies. Given the transformative potential of CRISPR technology in various fields, including medicine and agriculture, a widespread understanding of its principles is essential for informed public discourse and acceptance. By providing a readily accessible and affordable tool, LeDNA aims to democratize genetics and CRISPR education globally, fostering a more informed and engaged community.